
AMRX Technical Analysis Summary (NASDAQ)
Analyze AMRX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerAMRX Technical Analysis Summary (NASDAQ)
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Amneal Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Amneal Pharmaceuticals, Inc. is consolidating, awaiting a decisive move.
RSI (14): 56.12
Stochastic %K: 36.16
Williams %R: -42.62
Rate of Change (ROC): -1.55
Takeaway:Amneal Pharmaceuticals, Inc. shows neutral momentum, with indicators pointing to indecision.
MACD: 0.21
ADX: 19.98
ATR (14): 0.71
CCI (14): -12.40
Takeaway:Amneal Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Amneal Pharmaceuticals, Inc. trades around the middle band, reflecting balanced price action.
Takeaway:Amneal Pharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:AMRX shows neutral money flow, with no clear directional pressure.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Technical indicators for Amneal Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.